Author:
Jiang Ming-Hong,Chen Lin,Li Lin-Fang,Wu Hong-Ping,Jiang Li-Hua,Qian Yan-Zhen,Fang Guo-En,Xue Xu-Chao
Subject
Physiology (medical),Pharmacology,Physiology
Reference41 articles.
1. Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer;Haq;Womens Health,2009
2. Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers;Chia;J. Clin. Oncol,2008
3. HER2/neu role in breast cancer: From a prognostic foe to a predictive friend;Ferretti;Curr. Opin. Obstet. Gynecol,2007
4. Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer;Buzdar;Ann Oncol,2009
5. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer;Kurokawa;Clin. Cancer Res,2001
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献